CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Net Income Growth by Quarter and Year

Moderna Inc 's Net Income results by quarter and year




MRNA Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 1,465.00 4,868.00 -272.49 -4.08
III Quarter September 1,043.00 3,333.00 -233.64 -2.56
II Quarter June 2,197.00 2,780.00 -116.71 -2.78
I Quarter March 3,657.00 1,221.00 -124.23 -2.56
FY   8,362.00 12,202.00 -747.07 -11.98



MRNA Net Income fourth quarter 2022 Y/Y Growth Comment
Moderna Inc reported drop in Net Income in the fourth quarter 2022 by -69.91% to $ 1,465.00 millions, from the same quarter in 2021.
The fall in the fourth quarter 2022 Moderna Inc 's Net Income compares unfavorably to the Company's average Net Income doubling of 498.79%.

Among companies who have reported fourth quarter 2022 results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Net Income results in the fourth quarter 2022. While Moderna Inc ' s Net Income meltdown of -69.91% ranks overall at the positon no. 82 in the fourth quarter 2022.




MRNA Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -69.91 % - - -
III Quarter September -68.71 % - - -
II Quarter June -20.97 % - - -
I Quarter March 199.51 % - - -
FY   -31.47 % - - -

Financial Statements
Moderna Inc 's fourth quarter 2022 Net Income $ 1,465.00 millions MRNA's Income Statement
Moderna Inc 's fourth quarter 2021 Net Income $ 4,868.00 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Net Income Growth >>


MRNA Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December 40.46 % 46.05 % - -
III Quarter September -52.53 % 19.89 % - -
II Quarter June -39.92 % 127.68 % - -
I Quarter March -24.88 % - - -
FY (Year on Year)   -31.47 % - - -




Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #6
Overall #82

Net Income Y/Y Growth Statistics
High Average Low
2347.15 % 498.79 % -190.51 %
(Mar 31 2022)   (Mar 31 2017)
Net Income fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #6
Overall #82
Net Income Y/Y Growth Statistics
High Average Low
2347.15 % 498.79 % -190.51 %
(Mar 31 2022)   (Mar 31 2017)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Moderna Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
127.68 % 16.19 % -89.24 %
(Jun 30 2021)  


MRNA's IV. Quarter Q/Q Net Income Comment
Moderna Inc achieved in the IV. Quarter 2022 above company average sequential Net Income jump of 40.46%, to $ 1,465.00 millions, from $1,043.00 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Moderna Inc 's Net Income growth quarter on quarter, overall rank is 479.


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #36
Overall #479
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #36
Overall #479
Net Income Q/Q Growth Statistics
High Average Low
127.68 % 16.19 % -89.24 %
(Jun 30 2021)  


MRNA's IV. Quarter Q/Q Net Income Comment
Moderna Inc achieved in the IV. Quarter 2022 above company average sequential Net Income jump of 40.46%, to $ 1,465.00 millions, from $1,043.00 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Net Income quarter on quarter growth. While Moderna Inc 's Net Income growth quarter on quarter, overall rank is 479.


Moderna Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Net Income 12 Months Ending $ 8,362.00 $ 11,765.00 $ 14,055.00 $ 14,638.00 $ 12,202.00
Y / Y Net Income Growth (TTM) -31.47 % 66.61 % 302.16 % 2347.15 % -
Year on Year Net Income Growth Overall Ranking # 1702 # 2203 # 2134 # 2019 # 2019
Seqeuential Net Income Change (TTM) -28.92 % -16.29 % -3.98 % 19.96 % 72.8 %
Seq. Net Income Growth (TTM) Overall Ranking # 82 # 42 # 60 # 557 # 0




Cumulative Net Income growth Comment
For the 12 months ended Dec 31 2022 Moderna Inc reported a drop in Net Income by -31.47% year on year, to $8,362 millions, compare to the 66.61% growth at Sep 30 2022.

Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Total ranking has impoved so far to 1702, from total ranking in previous quarter at 2203.

Net Income TTM Q/Q Growth Statistics
High Average Low
2347.15 %
498.79 %
-190.51 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 0
Healthcare Sector # 2
Overall # 15

Net Income TTM Y/Y Growth Statistics
High Average Low
2347.15 %
227.71 %
-190.51 %
(Mar 31 2022)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 6
S&P 500 # 82
Cumulative Net Income growth Comment
For the 12 months ended Dec 31 2022 Moderna Inc reported a drop in Net Income by -31.47% year on year, to $8,362 millions, compare to the 66.61% growth at Sep 30 2022.

Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Total ranking has impoved so far to 1702, from total ranking in previous quarter at 2203.

Net Income TTM Q/Q Growth Statistics
High Average Low
2347.15 %
498.79 %
-190.51 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 0
Healthcare Sector # 2
Overall # 15

Net Income TTM Y/Y Growth Statistics
High Average Low
2347.15 %
227.71 %
-190.51 %
(Mar 31 2022)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 6
S&P 500 # 82




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
MRNA's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for MRNA's Competitors
Net Income Growth for Moderna Inc 's Suppliers
Net Income Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2022
Halozyme Therapeutics Inc -1.29%$ -1.293 millions
Inmode Ltd -2.15%$ -2.153 millions
Vanda Pharmaceuticals Inc -3.07%$ -3.066 millions
Pro dex Inc -4.97%$ -4.973 millions
Iradimed Corporation-5.63%$ -5.627 millions
Polypid Ltd -7.15%$ -7.145 millions
Amedisys Inc -7.24%$ -7.245 millions
Biontech Se-8.34%$ -8.337 millions
Lemaitre Vascular Inc -8.87%$ -8.874 millions
Alcon inc -10.90%$ -10.904 millions
Acadia Healthcare Company Inc -11.71%$ -11.709 millions
Intuitive Surgical Inc -12.02%$ -12.020 millions
Eton Pharmaceuticals Inc -12.22%$ -12.223 millions
Steris Plc-13.82%$ -13.815 millions
Envista Holdings Corporation-14.34%$ -14.336 millions
Pharming Group N v -14.52%$ -14.516 millions
Bristol myers Squibb Company-14.63%$ -14.629 millions
Amgen Inc -14.90%$ -14.903 millions
Stryker Corp-14.95%$ -14.955 millions
Exagen Inc -15.49%$ -15.489 millions
Zynex inc -16.21%$ -16.213 millions
Uniqure N v -17.07%$ -17.069 millions
Qiagen N v -17.44%$ -17.438 millions
Merck and Co Inc -19.90%$ -19.899 millions
Chemed Corporation-21.27%$ -21.266 millions
Rapid Micro Biosystems Inc -22.31%$ -22.312 millions
Select Medical Holdings Corp-23.04%$ -23.037 millions
Baxter International Inc -23.55%$ -23.554 millions
Integer Holdings Corporation-23.84%$ -23.843 millions
Becton Dickinson And Company-24.93%$ -24.926 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com